Description:

Title:  

Repurposing Anti-Pathogen FDA Vaccines to Augment Anti-Cancer Immune Responses

Speaker:

Andrew Zloza, MD, PhD, Associate Professor
Division of Hematology, Oncology, and Cell Therapy
Division of Precision and Translational Medicine
Department of Internal Medicine, Rush Medical College
Rush University Medical Center, Chicago, IL

Topic:

Since antiquity a link between pathogens and cancer has been recognized. However, how to harness this relationship as a cancer treatment has been elusive. We have discovered that the intra-tumoral use of anti-pathogen vaccines (like the seasonal “flu shot”) results in improved anti-tumor immune responses. Our work has the potential to elucidate new immuno-oncology mechanisms and repurpose already-approved FDA vaccines as a series of potent cancer immunotherapies. 

Host: Immunology Training Grant Postdocs and Graduate Students, Coordinating Host: Andrew Cogswell, Postdoc, Lab of Stephen Miller, PhD